Advertisement

Pediatric Nephrology

, Volume 6, Issue 1, pp 1–3 | Cite as

Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial

  • Patrick Niaudet
  • French Society of Paediatric Nephrology
Original Article

Abstract

Forty children with steroid-dependent idiopathic nephrotic syndrome and signs of steroid toxicity were randomly assigned to receive either cyclosporin 6 mg/kg body wt. per day for 3 months and at tapering doses over the next 3 months or chlorambucil at a cumulative dose of 8 mg/kg body wt. The two groups of patients did not differ significantly in sex distribution, age of onset of disease, duration of disease, number of relapses and histological findings. Of the 20 patients treated with cyclosporin, 4 relapsed before or on discontinuation of prednisone, 7 relapsed when the initial dose of cyclosporin was tapered, and 8 after withdrawal of cyclosporin. Of the 20 patients treated with chlorambucil, 14 relapsed while 6 were still in remission 27–49 months after completion of the treatment course. Thus the actuarial remission rate at 2 years was 45% after a course of chlorambucil compared with only 5% after a 3-month course of cyclosporin. We believe that children with steroid-dependent idiopathic nephrotic syndrome should be treated with a course of chlorambucil before resorting to cyclosporin.

Keywords

Public Health Steroid Cyclosporin Randomized Control Trial Prednisone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Broyer M (1988) La néphrose idiopathique et son traitement. Arch Fr Pediatr 45:1–4PubMedGoogle Scholar
  2. 2.
    Barratt TM, Osofsky FG, Berkowsky A, Soothill JF, Kay R (1975) Cyclophosphamide treatment in steroid sensitive nephrotic syndrome of childhood. Lancet I:55–58Google Scholar
  3. 3.
    Grupe WE, Makker SP, Ingelfinger JR (1976) Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 295:746–749PubMedGoogle Scholar
  4. 4.
    Pennisi AJ, Grushkin CM, Lieberman E (1976) Cyclophosphamide in the treatment of idiopathic nephrotic syndrome. Pediatrics 57:948–951PubMedGoogle Scholar
  5. 5.
    Cameron JS, Chantler C, Ogg CS, White RHR (1974) Long term stability or remission in nephrotic syndrome after treatment with cyclophosphamide. B M J 4:7–14Google Scholar
  6. 6.
    McDonald J, Murphy AV, Arneil GC (1974) Long term assessment of cyclophosphamide therapy for nephrosis. Lancet II:980–982Google Scholar
  7. 7.
    Baluarte HJ, Hiner L, Gruskin AB (1978) Chlorambucil dosage in frequently relapsing nephrotic syndrome: a controlled clinical trial. J Pediatr 92:295–298PubMedGoogle Scholar
  8. 8.
    Arbeitsgemeinschaft für Pädiatrische Nephrologie (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306:451–454Google Scholar
  9. 9.
    Arbeitsgemeinschaft für Pädiatrische Nephrologie (1987) Cyclophosphamide treatment of steroid dependent nephrotic syndrome comparison of eigth week with 12 week course. Arch Dis Child 62:1102–1106Google Scholar
  10. 10.
    Williams SA, Makker SP, Ingelfinger JR, Grupe WE (1989) Long term evaluation of chlorambucil plus prednisone in idiopathic nephrotic syndrome of childhood. N Engl J Med 302:929–933Google Scholar
  11. 11.
    Penso J, Lippe B, Ehrlich R, Smith FC (1974) Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome. J Pediatr 84:831–836PubMedGoogle Scholar
  12. 12.
    Guesry P, Lenoir G, Broyer M (1978) Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Pediatr 92:299–303PubMedGoogle Scholar
  13. 13.
    Hsu AC, Folami AO, Bain J, Rance CP (1979) Gonadal functions in males treated with cyclophosphamide for nephrotic syndrome. Fertil Steril 31:173–177PubMedGoogle Scholar
  14. 14.
    Callis L, Nieto J, Vila A, Rende J (1980) Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity. J Pediatr 97:653–656PubMedGoogle Scholar
  15. 15.
    Trompeter RS, Evans PR, Barratt TM (1981) Gonadal function in boys with steroid responsive nephrotic syndrome treated with cyclophosphamide for short periods. Lancet I:1177–1180Google Scholar
  16. 16.
    Capodicasa G, De Santo NG, Nuzzi F, Giordano C (1986) Cyclosporin A in nephrotic syndrome of childhood: a 14 month experience. Int J Pediatr Nephrol 7:69–72PubMedGoogle Scholar
  17. 17.
    Lagrue G, Laurent J, Belghiti D, Robeva R (1986) Cyclosporin and idiopathic nephrotic syndrome. Lancet II:692–693Google Scholar
  18. 18.
    Niaudet P, Habib R, Tête MJ, Hinglais N, Broyer M (1987) Cyclosporine in the treatment of idiopathic nephrotic syndrome in children. Pediatr Nephrol 1:566–573PubMedGoogle Scholar
  19. 19.
    Brodehl J, Hoyer PF, Oemar BS, Heimchen U, Wonigeit K (1988) Cyclosporin treatment of nephrotic syndrome in children. Transplant Proc 20 [Suppl 4]:269–274Google Scholar
  20. 20.
    Mentser M, Shannon B, Mahan JD (1988) Cyclosporin treatment of frequently relapsing minimal change nephrotic syndrome in children. Response to therapy and evidence for a T-cell abnormality. Kidney Int 33:329Google Scholar
  21. 21.
    Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR (1988) Cyclosporin A induced remission in relapsing nephrotic syndrome in children. Kidney Int 33:729–734PubMedGoogle Scholar
  22. 22.
    Meyrier A and Collaborative Group of the Société de Néphrologie (1989) Cyclosporin in the treatment of nephrosis. Am J Nephrol 9 [Suppl 1]:65–71Google Scholar
  23. 23.
    Kitano Y, Yoshikawa N, Tanaka R, Nakamura H, Nimomiya M, Ito H (1990) Cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 4:474–477PubMedGoogle Scholar
  24. 24.
    Myers BD (1986) Cyclosporin nephrotoxicity. Kidney Int 30:964–976PubMedGoogle Scholar
  25. 25.
    Niaudet P, Broyer M, Habib R (1990) Evaluation of nephrotoxicity by sequential biopsies in 38 children with idiopathic nephrosis treated with cyclosporin A. Kidney Int 37:260Google Scholar

Copyright information

© IPNA 1992

Authors and Affiliations

  • Patrick Niaudet
    • 1
  • French Society of Paediatric Nephrology
    • 1
  1. 1.Department of Paediatric NephrologyHôpital Necker-Enfants-MaladesParis Cedex 15France

Personalised recommendations